SBI Securities’s Jasper Therapeutics JSPR Stock Holding History

SBI Securities’s Portfolio JSPR Stock Details JSPR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$27	Sell	64 -1	-2%	-$1	﹤0.01%	3787
2026 Q1	$57	Hold	65	–	–	﹤0.01%	3546
2025 Q4	$119	Sell	65 -1	-2%	-$2	﹤0.01%	3359
2025 Q3	$157	Sell	66 -85	-56%	-$258	﹤0.01%	3395
2025 Q2	$838	Hold	151	–	–	﹤0.01%	2757
2025 Q1	$649	Buy	151 +145	+2,417%	+$965	﹤0.01%	2764
2024 Q4	$128	Buy	+6	New	+$125	﹤0.01%	3386

SBI Securities's JSPR Position: Q2 2026 in Review

SBI Securities reduced its Jasper Therapeutics (JSPR) stake by 1.5% in Q2 2026, selling an estimated $1 and leaving 64 shares worth $27. The position accounts for ﹤0.01% of the portfolio, ranked #3787.

SBI Securities first reported a position in JSPR in Q4 2024 and has held it in 7 quarters since. The position peaked at $838 in Q2 2025. 1 fund tracked by Wall St. Rank holds JSPR as of Q2 2026.

SBI Securities held 64 shares of Jasper Therapeutics worth $27 as of Q2 2026.
SBI Securities sold 1 Jasper Therapeutics share in Q2 2026, an estimated $1.
Jasper Therapeutics made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #3787 holding.
SBI Securities first reported a position in Jasper Therapeutics in Q4 2024 and has held it in 7 quarters since.
SBI Securities's Jasper Therapeutics position peaked at $838 in Q2 2025.
1 fund tracked by Wall St. Rank held Jasper Therapeutics as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.